PharmTech News

Feb 27, 2015
By PharmTech Editors
FDA announced that it would postpone a meeting that would be critical for the advancement of Celltrion’s Remicade biosimilar in the US.
Feb 26, 2015
FDA approved Actavis’ antibiotic Avycaz designed to combat drug-resistant bacteria.
Feb 25, 2015
Johnson & Johnson will pay $2.5 million to a plaintiff who developed gynecomastia after using Risperdal.
Feb 25, 2015
Remsima will now be available for patients in 12 additional countries in the European Union.
Feb 25, 2015
By PharmTech Editors
Turing Pharmaceuticals announced the launch of its company, the acquisition of three assets from Retrophin, and a new senior management team.
Feb 24, 2015
By PharmTech Editors
SGS has invested in additional modules for its COBAS 6000 analysis system in a move to expand its biomarker analytical capabilities at its Poitiers facility in France.
Feb 24, 2015
By PharmTech Editors
Aprecia Pharmaceuticals' new facility in Ohio will create 150 jobs.
Pharmaceutical Technology: Feb 24, 2015
By PharmTech Editors
The company voluntarily recalls product due to FDA observations of potential sterility problems.
Pharmaceutical Technology: Feb 23, 2015
By PharmTech Editors
Valeant announced that it acquired Salix Pharmaceuticals for approximately $14.5 billion, which could result in annual cost savings of $500 million.
Pharmaceutical Technology: Feb 23, 2015
By PharmTech Editors
The agency cites Apotex’s Bangalore facility with quality system failures.